Open label proof of efficacy trial of DNTH103 in Cold Agglutinin Disease
Latest Information Update: 17 Jan 2024
At a glance
- Drugs DNTH 103 (Primary)
- Indications Autoimmune haemolytic anaemia
- Focus Therapeutic Use
Most Recent Events
- 09 May 2023 New trial record
- 03 May 2023 According to a Magenta Therapeutics media release, data from this trial is expected in the second half of 2024.